(Q38028344)

27 August 2017

title

Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus (English)

1 reference

27 August 2017

0 references

1 reference

Alexandra Kautzky-Willer

object named as

Alexandra Kautzky-Willer

series ordinal

3

0 references

author name string

Sazan Rasul

series ordinal

1

1 reference

27 August 2017

Ludwig Wagner

series ordinal

2

1 reference

27 August 2017

publication date

21 July 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

42

1 reference

27 August 2017

issue

3

1 reference

27 August 2017

page(s)

496-505

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-012-9754-4

27 August 2017

exact match

0 references

cites work

Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Insulin resistance in nonobese patients with polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Influence of obesity and metabolic dysfunction on the endothelial control in the coronary circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Fetuin-A protects against atherosclerotic calcification in CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Circulating angiopoietin-2 levels increase with progress of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Gender differences in insulin resistance, body composition, and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Obesidomics: contribution of adipose tissue secretome analysis to obesity research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Apelin, diabetes, and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Adiponectin action from head to toe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

The impact of liver fat vs visceral fat in determining categories of prediabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

The nucleotide and partial amino acid sequences of rat fetuin. Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Plasma fetuin-A levels and the risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Fetuin-null mice are protected against obesity and insulin resistance associated with aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Fetuin-A and incident diabetes mellitus in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Serum fetuin-A is an independent marker of insulin resistance in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Levels of fetuin-A relate to the levels of bone turnover biomarkers in male and female patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Fetuin-A Characteristics during and after Pregnancy: Result from a Case Control Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Plasma fetuin-A concentrations in young and older high- and low-active men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Fetuin-A induces cytokine expression and suppresses adiponectin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

AHSG gene variation is not associated with regional body fat distribution--a magnetic resonance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Fatty liver: a novel component of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Angiogenesis-dependent diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Angiogenesis in the pathogenesis of inflammatory joint and lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Adipose tissue mass can be regulated through the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Clinician guide to angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Angiopoietins: a link between angiogenesis and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Angiopoietin-2 levels in glucose intolerance, hypertension, and metabolic syndrome in Asian Indians (Chennai Urban Rural Epidemiology Study-74).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Clinical and genetic correlates of circulating angiopoietin-2 and soluble Tie-2 in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Angiogenic factors are elevated in overweight and obese individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Overexpression of angiopoietin-2 impairs myocardial angiogenesis and exacerbates cardiac fibrosis in the diabetic db/db mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Angiopoietin/Tie2 pathway mediates type 2 diabetes induced vascular damage after cerebral stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Angiopoietin 2 alters pancreatic vascularization in diabetic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Abnormal regulation of neo-vascularisation in deep partial thickness scalds in rats with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

High glucose and elevated fatty acids suppress signaling by the endothelium protective ligand angiopoietin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Pancreatic islet production of vascular endothelial growth factor--a is essential for islet vascularization, revascularization, and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Angiopoietin-1 protects myocardial endothelial cell function blunted by angiopoietin-2 and high glucose condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Visceral obesity and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Relations of adiponectin to levels of metabolic parameters and sexual hormones in elderly type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Effect of fatty acids on endothelium-dependent relaxation in the rabbit aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Cardiovascular biology of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Protein array reveals differentially expressed proteins in subcutaneous adipose tissue in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Inflammation, a link between obesity and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

The essential role of fetuin in the serum-induced calcification of collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Fetuin-A and BMD in older persons: the Health Aging and Body Composition (Health ABC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Vascular calcification in maintenance hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Fetuin-A is inversely associated with coronary artery calcification in community-living persons: the Multi-Ethnic Study of Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetes and body mass index?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Association of AHSG Gene Polymorphisms With Fetuin-A Plasma Levels and Cardiovascular Diseases in the EPIC-Potsdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9754-4

Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis

21 January 2018

1 reference

12 December 2020

Prevalence of and risk factors for hepatic steatosis in Northern Italy

1 reference

12 December 2020

Type II diabetes abrogates sex differences in endothelial function in premenopausal women

1 reference

12 December 2020

Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin

1 reference

12 December 2020

The relationship of fetuin-A and lactoferrin with bone mass in elderly women

1 reference

12 December 2020

Adipose tissue as an endocrine and paracrine organ

1 reference

12 December 2020

Expression and prognostic significance of angiopoietin in colorectal carcinoma

1 reference

12 December 2020

Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis

1 reference

12 December 2020

Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects

1 reference

12 December 2020

Associations between plasma C-reactive protein levels and the severities of coronary and aortic atherosclerosis

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

12 December 2020

Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

1 reference

12 December 2020

Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro

1 reference

12 December 2020

The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis

1 reference

12 December 2020

Association of hypoadiponectinemia with coronary artery disease in men

1 reference

12 December 2020

Angiopoietin-1 production in islets improves islet engraftment and protects islets from cytokine-induced apoptosis

1 reference

12 December 2020

10.1007/S12020-012-9754-4

Identifiers

DOI

1 reference

27 August 2017

1 reference